Chul Hee Kim
Overview
Explore the profile of Chul Hee Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koh J, Lee M, Pham T, Heo B, Choi S, Lee S, et al.
Blood Res
. 2025 Jan;
60(1):5.
PMID: 39812969
Background: Post-transplantation cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) are common prophylactic strategies for graft-versus-host disease (GVHD) after haploidentical hematopoietic stem cell transplantation (haplo-HSCT). Interleukin (IL)-6 is a surrogate marker for...
2.
Park Y, Kim J, Ryu Y, Moon J, Shin Y, Kim J, et al.
Cancer Biol Ther
. 2023 Aug;
24(1):2246208.
PMID: 37621144
Significant improvement in targeted therapy for colorectal cancer (CRC) has occurred over the past few decades since the approval of the EGFR inhibitor cetuximab. However, cetuximab is used only for...
3.
Kim M, Lee K, Oh K, Kim C, Kil H, Lee Y, et al.
Biochem Biophys Res Commun
. 2023 Feb;
651:107-113.
PMID: 36801611
We have compared the similarity of the in vivo distribution of the prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agents [F]DCFPyL, [Ga]galdotadipep, and [Ga]PSMA-11. This study is designed...
4.
Kim D, Ryu Y, Lee E, Koh D, Moon J, Jung S, et al.
Invest New Drugs
. 2022 Dec;
41(1):105-114.
PMID: 36538258
Dysregulated Wnt signaling is associated with malignant oncogenic transformation, especially in colon cancer. Recently, numerous drugs have been developed based on tumorigenesis biomarkers, thus having high potential as drug targets....
5.
Hwang J, Lee M, Chung T, Lee H, Lee J, Choi S, et al.
Crit Care
. 2021 Jan;
25(1):20.
PMID: 33413559
Background: Sepsis has a high mortality rate, but no specific drug has been proven effective, prompting the development of new drugs. Immunologically, sepsis can involve hyperinflammation, immune paralysis, or both,...
6.
Kim H, Lee M, Kim E, Bae S, Choe J, Kim C, et al.
Diabetes Metab J
. 2019 Jun;
43(5):627-639.
PMID: 31237125
Background: To elucidate longitudinal changes of complex body composition phenotypes and their association with incident type 2 diabetes mellitus. Methods: A total of 17,280 (mean age, 48.1±8.2 years) Korean adults...
7.
Kang S, Kim C, Lee K, Kim D
Org Lett
. 2019 Apr;
21(9):3062-3066.
PMID: 30990693
We designed and synthesized a bis-triethylene glycolic crown-5-calix[4]arene (BTC5A) as a multifunctional promoter for nucleophilic fluorination using KF. The synergetic effect of the calix-crown moiety and ethylene glycols of BTC5A...
8.
Choi D, Jung C, Mok J, Kim C, Kang S, Kim B
Endocrinol Metab (Seoul)
. 2018 Sep;
33(3):387-394.
PMID: 30229578
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are expected to improve the liver function of patients with non-alcoholic fatty liver disease (NAFLD) combined type 2 diabetes mellitus (T2DM) by its characteristic mechanism....
9.
Kim C, Choi Y, Moon J, Kim D, Lee S, Lee H, et al.
Korean J Intern Med
. 2017 Nov;
34(2):383-389.
PMID: 29172399
Background/aims: Few studies have addressed whether there are differences in clinical efficacy between intravenous methylprednisolone (methyl-Pd) and intravenous immunoglobulin (IVIg) use. Methods: We retrospectively compared platelet responses and toxicities associated...
10.
Kim H, Mok J, Kim C, Kim Y, Kim S, Park H, et al.
Endocr Res
. 2016 Dec;
42(2):154-162.
PMID: 27936964
Background: Fine-needle aspiration biopsy (FNAB) cannot distinguish a follicular thyroid carcinoma (FTC) from a follicular adenoma in follicular lesions. We designed this study to determine whether the preoperative thyroglobulin (Tg)...